ENTITY
Merck & Co

Merck & Co (MRK US)

227
Analysis
Health CareUnited States
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
more
bullishMerck & Co
26 Jun 2025 20:00

Merck & Co. Unleashes a Bold Oncology Offensive—Will KEYTRUDA’s Expansion Rewrite Cancer Care?

Merck & Co., Inc. reported its first-quarter 2025 financial results with a mix of strengths and challenges. Overall, the company maintained...

Logo
98 Views
Share
bullishMerck & Co
26 Mar 2025 05:00

Merck’s $25 Billion Lifeline Is About to Expire — Here’s the Bold Plan to Replace It!

Merck & Co.'s fourth-quarter 2024 financial performance reflects a complex landscape of strength in some areas alongside challenges in...

Logo
178 Views
Share
bullishMerck & Co
22 Nov 2024 07:00

Merck & Co. Inc.: Expanding Oncology Portfolio through KEYTRUDA Developments & Partnership Collaborations To Shape the Future! - Major Drivers

Merck & Co. has demonstrated robust operational performance and strategic advances in its third quarter earnings, navigating through both...

Logo
439 Views
Share
bullishMerck & Co
31 Oct 2024 08:17Podcast

Merck & Co: Blockbuster Drugs - [Business Breakdowns, EP.189]

Business Breakdowns explores Merck, a leading pharmaceutical company known for innovation in oncology and future drug pipeline, navigating...

Logo
943 Views
Share
bullishMerck & Co
03 Sep 2024 08:00

Merck & Co.: Expanding Market for GARDASIL

Merck & Co.'s second quarter earnings call underscored both the progress and challenges faced by the company as it pushes forward in an...

Logo
235 Views
Share
x